ONCOSYNE AS
Developing cancer treatments using patient-derived 3D tumoroid models.
Oversigt
- Ukendt
- Medarbejdere
- 4.4mio NOK
- Omsætning
- 2020
- Grundlagt
Nøglebeslutningstagere
Jarle Bruun
CEO and co-founder
Peter W. Eide
CTO and co-founder
Nicolas Pasquier
Scientist
Amit Roopan
Summer intern
+1 flere kontakter i Funnelfeedr
Beskrivelse
Oncosyne operates at the forefront of precision oncology, utilizing its proprietary iCAN tumoroid platform. This platform creates living, patient-derived 3D tumor models that accurately mimic the characteristics of a patient's original cancer. For the pharmaceutical industry, Oncosyne offers compreh...